Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 298
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Psilocybin Data Study Agreement Reached Between Silo Wellness and Ehave Using...
Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies
Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics...
COMPASS Pathways granted two US patents
Mydecine Innovations Group Announces Migration to NEO Exchange
PT236 – Dr. Carl Hart – Drugs: Honesty, Responsibility, and Logic
Psychedelic Synesthesia: Smell That Tune
Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation...
Mindset Pharma Announces $5 Million Bought Deal Financing
MindMed Announces Inclusion in FTSE Russell Indexes
Load more